Dent Neurologic


Fran M. Gengo


Dr. Gengo serves as Director of Neuropharmacology and the Research Director for the Acute Stroke Treatment Program at DENT, as well as the the Chief Science Officer for DENT’s research affiliate, DNRC. Dr. Gengo is also the Neuropharmacological Director for the DENT Cannabis Clinic.


Dr. Gengo is located at DENT Tower in Amherst.

He is currently involved in several protocols of thrombolytics and neuroprotective agents. In addition, he is an Associate Professor of Pharmacy and Neurology and a Clinical Assistant Professor of Neurosurgery at the SUNY at Buffalo School of Medicine.

Dr. Gengo has published numerous papers on the effects of various drugs on the central nervous system and his research entails abstraction and statistical analysis of data acquired from several modalities.


- Neurology
- Neuropharmacology
- Pharmacotherapy

Board Certifications​

- 2005 Neurology
- 2011 Neuroimaging
- 2016 Neurology


See publications for Fran M. Gengo, PharmD

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with DENT Neurologic Institute)


- Director of Neuropharmacology
- Research Director, DENT Acute Stroke Treatment Program
- Chief Science Officer, DENT’s research affiliate, DNRC.
- Neuropharmacological Director, DENT Cannabis Clinic.
- Associate Professor of Pharmacy and Neurology, SUNY at Buffalo School of Medicine
- Clinical Assistant Professor of Neurosurgery, SUNY at Buffalo School of Medicine.


Medical / Graduate Education
Philadelphia College of Pharmacy and Science, Philadelphia, PA

SUNY at Buffalo, Department of Pharmaceutics, Buffalo, NY – Pharmacokinetics and Biopharmaceutics

Open Clinical Trials

Dizziness and Balance

Hearing Aid Research

Hearing Aid Research Are you interested in participating in hearing aid research?  Dr. Zhang is collaborating with Dr. Wei Sun at UB and is recruiting ...
Read More →


BIOGEN CELIA In this study, researchers will learn more about a study drug called BIIB080. The study will focus on participants with mild cognitive impairment ...
Read More →
Parkisons Disease

Jazz Patagonia

JAZZ PATAGONIA (Parkinson’s Disease) This is a 17-week double-blind, placebo-controlled, randomized, flexible-dosing, parallel-group, multicenter study designed to evaluate the efficacy and safety of suvecaltamide for ...
Read More →

CGBG Study

We are looking for adults ages 18 to 55 who have been diagnosed with migraine. The CGBC Study will consist of five visits over a ...
Read More →


ADCS BENFO-TEAM The purpose of this study is to learn more about the safety, effectiveness and tolerability of the study drug called Benfotiamine which may ...
Read More →

STARS and STARS Extension

Studies to Assess the Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
Read More →


SUVEN CTP3S1502HT6 (Alzheimer’s Disease with Agitation) This study will be conducted to evaluate the efficacy, safety, tolerability, and pharmacokinetics of masupirdine compared to placebo for ...
Read More →

IGC Pharma

IGC PHARMA (Alzheimer’s Disease with Agitation) This is a trial of the safety and efficacy of IGC-AD1 on Agitation in Participants with Dementia due to ...
Read More →


ACADIA RADIANT (Alzheimer’s Disease Psychosis) In this study, researchers will evaluate ACP-204 in patients with Alzheimer’s Disease Psychosis. Inclusion Criteria:  50 years to 95  years ...
Read More →
Treatment-Resistant Depression


A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in ...
Read More →

Want to participate in a study?

Fill out the form below and one of our Research Coordinators will be in contact with you as soon as possible. If we currently do not have a study that is currently available for you, we will add you to our database for future studies.

Subscribe To Our Newsletter

Sign up to receive email updates on announcements, new services added, company updates & more!

Call us to schedule an appointment

Our entire team, from customer service to patient providers, is focused on the central mission to deliver superior clinical care, advanced neurodiagnostics, clinical research and education that will assist our patients in maximizing their quality of life. We strive to exceed the expectations of our patients, clinical partnerships and community partners.

Scroll to Top